investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Recombinant Toxins to Treat Hematologic Malignancies
Robert Kreitman
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Tadeusz Robak
Medical University of Lodz
Łódź, Poland
Thomas Decker
Ludwig Maximilian University of Munich
Munich, Germany
Ingo Ringshausen
Ludwig Maximilian University of Munich
Munich, Germany
Francesco Forconi
University of Siena
Siena, Italy
Robert Kreitman
National Cancer Institute (NIH)
Rockville, United States
Related projects
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Hematology and hematologic malignancies
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Hematology and hematologic malignancies
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Hematology and hematologic malignancies
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Hematology and hematologic malignancies
Monica J Justice
The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Activation of Proto-Oncogenes by Chromosomal Translocation
Leukaemia
Hematology and hematologic malignancies
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Hematology and hematologic malignancies
James Kochenderfer
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
Leukaemia
Hematology and hematologic malignancies
George Calin
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
